[04:30:25 PM] => Myiris : Welcome to the live chat session at myiris.com

[04:31:33 PM] => Myiris: Mr S. Sankarnarayanan, Fund Manager, Tata Mutual Fund will be joining us shortly

[04:32:39 PM] => DISCLAIMER:

[04:32:52 PM] => Mr S. Sankarnarayanan, is the Fund Manager, Tata Mutual Fund. At the time of this conversation / chat, Mr. Sankarnarayanan may or may not have positions in the stocks mentioned below, although holdings may change at any time.
[04:34:18 PM] => The views expressed by Mr S. Sankarnarayanan is based upon information that he considers reliable, but does not represent that it is accurate or complete, and it should not be relied upon as such. Mr. Sankarnarayanan, his company and its affiliates, officers, directors, partners, and employees may, from time to time, have long or short positions in, buy or sell and deal as principal in the securities, or derivatives thereof, of companies mentioned herein and may take positions inconsistent with the views expressed. None of the information contained herein constitutes, or is intended to constitute a recommendation of any particular security or trading strategy or a determination that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person. You should consult with and rely upon your own advisors whether and how to use such information in making any investment decision.

[04:34:43 PM] => Lastly the views expressed by Mr. Sankarnarayanan have no bearing whatsoever with that of IRIS Ltd. IRIS does not guarantee the accuracy, adequacy or completeness of any information and is not responsible for any errors or omissions or for the results obtained from the use of such information. IRIS especially states that it has no financial liability whatsoever to any user on account of the use of information provided on its website www.myiris.com.

[04:35:09 PM] => Myiris : Welcome to the chat session, Mr. Sankarnarayanan

[04:36:02 PM] => Razdan : Considering that retaliation by US is imminent what's your outlook on the rupee and the oil front?
[04:36:49 PM] => SS : The rupee may see volatility over this period and oil prices would also be volatile.

[04:37:31 PM] => Sastri56 : When do you think the RBI will cut interest rates considering Fed has already announced a rate cut?
[04:38:34 PM] => SS : In my opinion, RBI may not cut interest rates in the short term.

[04:41:24 PM] => Amit Sinha : It looks like the US economy will slip into a recession. What's your outlook on the Indian economy?
[04:41:44 PM] => SS : The Indian economy is also poised very precariously as data suggests considerable slowdown in manufacturing.

[04:42:48 PM] => M K Goyanka : Sir, what is the impact of Inflation and fluctuations in Rupee value on Income Funds, please tell by siting suitable examples. Also please let me know what is the impact of Inflation and Rupee value on imports and exports.
[04:43:39 PM] => SS : Inflation reduces the real interest rate in the economy and naturally higher inflation tends to tends to increase yields, rupee depreciation tends to reduce money market liquidity and affects interest rates over the short term. In effect inflation is a more fundamental factor and forex fluctuations is a technical factor.

[04:44:46 PM] => Trader 90 : When do you think health insurance and related benefits will improve in India?
[04:46:25 PM] => SS : I think it will depend on govt policies, otherwise we see it taking shape over the next 3-5 years.

[04:47:31 PM] => Trader 90 : Considering that most MNC companies are seriously looking towards delisting their Indian subsidiaries, does it make sense to buy into MNC pharma stocks at all?
[04:48:29 PM] => SS : I do not think that it makes any sense to buy MNC pharma, except a few which do not have any intentions as of now. E.g. - Aventis Phama.

[04:49:49 PM] => Trader 90 : Are frontline pharma stocks on the way to becoming another bubble story?
[04:50:55 PM] => SS : I do not think so as they have hardly moved now to categorize it that way, but we have to wait and see.

[04:51:50 PM] => Trader 90 : Why is the buying interest not spreading to second line pharma stocks?
[04:52:34 PM] => SS : It always happens later as they are second in line.

[04:54:32 PM] => guptadk_jal : Whether Global Tele has cash worth 500 crores?
[04:54:47 PM] => SS : I cannot comment on that.

[04:56:21 PM] => Ajit Naik : How do you see the GILT prices movement over the next 30 days, considering the fact that they have fallen quite drastically since 11-September till now?
[04:58:06 PM] => SS : We have already seen a sharp revival of prices.

[05:00:31 PM] => Bipin TP : What is your opinion about tech mutual funds?
[05:00:56 PM] => SS : I think it will recover with the recovery in the US economy.

[05:01:24 PM] => msksiil : What is the outlook of debt mutual funds?
[05:03:57 PM] => SS : Debt mutual funds have shown quite a performance in the last six months, I think from now on, it would be more realistic.

[05:06:28 PM] => nitin_pareek : I am a student of management in IISc Bangalore. I am interested in quantitative and IT tools used as decision support system for financial companies specially those involved in capital market. Would u please inform me about such tools used in TATA MF.
[05:07:16 PM] => SS : We use company databases for equity research and a technical analysis software for trends.

[05:08:18 PM] => pranavparikh : How do you calculate the intrinsic value of software industry?
[05:09:26 PM] => SS : Quite difficult to put it in one sentence!

[05:09:54 PM] => Raghuram : From the subject it seems you are bullish about the pharma sector? What do you see as the prime factors, which drive the sector forward?
[05:11:58 PM] => SS : The most important reason for the software industry to take off was the Internet boom and the resultant boom in IT spending. We see the generics market potential to be the prime driver for pharma stocks to be out performers.

[05:13:44 PM] => kiranktk : Can I buy Fujitsu ICIM at the current price of 55 Rs ?
[05:14:19 PM] => SS : The new managing director of Fujistu ICIM has an onerous task in front of him given the difficult market conditions.

[05:15:06 PM] => kiranktk : Is IBP a good buy at the current price, if so what is your price target once divestment takes place?
[05:15:30 PM] => SS : I think the disinvestment program has to take place soon, otherwise the current price could prove to be the top for the stock.

[05:16:09 PM] => RBehl : Where do you see the Dr. Reddy scrip 1 year from now?
[05:16:31 PM] => SS : The stock could easily double in a year’s time.

[05:17:00 PM] => Prasad : How long will it take for the markets to turn around and do you see the market back to where it was at the peak of the IT boom?
[05:18:52 PM] => SS : I think the recovery will be longer and would be better to pep your portfolio with Dr.Reddys and Ranbaxy as a cure to the IT ills.

[05:19:15 PM] => Reddy B : Is there a shift towards debt funds from equity after the US attacks?
[05:19:50 PM] => SS : I do not think so.

[05:20:35 PM] => Arun A : Whats the internal benchmarking system that you use while managing your funds?
[05:21:17 PM] => SS : We benchmark against the BSE Sensex for our equity funds.

[05:24:01 PM] => ram_kumar_h : I am a software professional, male, 26 years old. Could you please suggest schemes, which will help me, save for a house, as well as get IT benefits.
[05:24:40 PM] => SS : As far as equity schemes with IT benefits are concerned u could invest in a Tax Saving Fund.

[05:25:34 PM] => sk200110 : Why does Cadila trade at such a low PE? At this level, does it
[05:27:33 PM] => SS : It does offer scope for appreciation but I think it is better to stick to quality companies like Dr.Reddys and Ranbaxy where the upside is better.

[05:39:21 PM] => Khans : Do you think Biotech is going to be the next big thing?
[05:40:01 PM] => SS : As far as Indian companies are concerned, biogeneric opportunity exists. Biotech basic research is still some way off.

[05:40:26 PM] => Shilpa : Whats your outlook about the bond market?
[05:40:56 PM] => SS : Its going to be choppy.

[05:41:36 PM] => Raghu87 : What is the average duration in your debt portfolio?
[05:41:49 PM] => SS : Average duration should be about 3.2.

[05:44:47 PM] => Myiris : Thats all we have time for in this chat session at myiris.com

[05:48:26 PM] => Myiris : We thank you all for your participation.